Kumar Ashok, Sarangi Yajnadatta, Gupta Annapurna, Sharma Aarti
Department of Surgical Gastroenterology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow 226014, Uttar Pradesh, India.
Division of Haematology, Mayo Clinic Arizona, Phoenix, AZ 85054, United States.
World J Clin Oncol. 2024 Jun 24;15(6):695-716. doi: 10.5306/wjco.v15.i6.695.
Gallbladder cancer (GBC) is one of the commonest biliary malignancies seen in India, Argentina, and Japan. The disease has dismal outcome as it is detected quite late due to nonspecific symptoms and signs. Early detection is the only way to improve the outcome. There have been several advances in basic as well as clinical research in the hepatobiliary and pancreatic diseases in the West and other developed countries but not enough has been done in GBC. Therefore, it is important and the responsibility of the countries with high burden of GBC to find solutions to the many unanswered questions like etiopathogenesis, early diagnosis, treatment, and prognostication. As India being one of the largest hubs for GBC in the world, it is important to know how the country has progressed on GBC. In this review, we will discuss the outcome of the publications from India highlighting the work and the developments taken place in past several decades both in basic and clinical research.
胆囊癌(GBC)是在印度、阿根廷和日本常见的胆道恶性肿瘤之一。由于症状和体征不具特异性,该疾病往往在较晚阶段才被发现,预后较差。早期检测是改善预后的唯一途径。在西方和其他发达国家,肝胆胰疾病的基础和临床研究已经取得了多项进展,但在胆囊癌方面的研究还不够充分。因此,胆囊癌负担较重的国家有责任找到解决许多未解决问题的方法,如病因发病机制、早期诊断、治疗和预后评估。作为世界上胆囊癌最大的高发地区之一,了解印度在胆囊癌方面的进展情况非常重要。在这篇综述中,我们将讨论印度发表的研究成果,重点介绍过去几十年来基础和临床研究方面的工作及进展。